Global Hepatitis B Vaccination Market Research Report 2026(Status and Outlook)

May 2026 | 136 pages | ID: G20C1A560267EN
Bosson Research

Abstracts

Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.The hepatitis B vaccination market is driven by the increasing focus on disease prevention and the rising awareness of the importance of immunization. Hepatitis B vaccines provide essential protection against the hepatitis B virus (HBV), which can cause chronic liver infections and increase the risk of liver cirrhosis and cancer. The rise in the prevalence of hepatitis B infections and the need for effective control of the disease contribute to market growth as vaccination plays a crucial role in reducing transmission and preventing complications. Moreover, advancements in vaccine technology, such as the development of combination vaccines and birth dose administration, have improved vaccine accessibility and coverage. However, the market also faces challenges, including vaccine supply limitations and the need for ongoing public health initiatives to address barriers to vaccination, such as vaccine hesitancy and lack of awareness. Additionally, ensuring equitable access to hepatitis B vaccines and increasing vaccination rates in high-risk populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable hepatitis B vaccines, collaborate with healthcare providers and governments to implement vaccination programs, and address the challenges to meet the increasing demand for effective and accessible protection against hepatitis B.

The global Hepatitis B Vaccination market size was estimated at USD 1094.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 1.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Hepatitis B Vaccination market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Hepatitis B Vaccination market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hepatitis B Vaccination market.

Global Hepatitis B Vaccination Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• GSK
• NCPC
• Merck
• Bio Kangtai
• Dynavax
• Hissen
• KM Biologics
• LG Life Sciences
• Serum Institute

Market Segmentation (by Type)

• Yeast Derived
• CHO Derived

Market Segmentation (by Application)

• Children
• Adult

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Hepatitis B Vaccination Market

Overview of the regional outlook of the Hepatitis B Vaccination Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hepatitis B Vaccination Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Hepatitis B Vaccination, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Hepatitis B Vaccination
1.2 Key Market Segments
  1.2.1 Hepatitis B Vaccination Segment by Type
  1.2.2 Hepatitis B Vaccination Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 HEPATITIS B VACCINATION MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Hepatitis B Vaccination Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Hepatitis B Vaccination Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 HEPATITIS B VACCINATION MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Hepatitis B Vaccination Product Life Cycle
3.3 Global Hepatitis B Vaccination Sales by Manufacturers (2020-2025)
3.4 Global Hepatitis B Vaccination Revenue Market Share by Manufacturers (2020-2025)
3.5 Hepatitis B Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hepatitis B Vaccination Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Hepatitis B Vaccination Market Competitive Situation and Trends
  3.8.1 Hepatitis B Vaccination Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Hepatitis B Vaccination Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 HEPATITIS B VACCINATION INDUSTRY CHAIN ANALYSIS

4.1 Hepatitis B Vaccination Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF HEPATITIS B VACCINATION MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Hepatitis B Vaccination Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Hepatitis B Vaccination Market
5.7 ESG Ratings of Leading Companies

6 HEPATITIS B VACCINATION MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hepatitis B Vaccination Sales Market Share by Type (2020-2025)
6.3 Global Hepatitis B Vaccination Market Size by Type (2020-2025)
6.4 Global Hepatitis B Vaccination Price by Type (2020-2025)

7 HEPATITIS B VACCINATION MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hepatitis B Vaccination Market Sales by Application (2020-2025)
7.3 Global Hepatitis B Vaccination Market Size (M USD) by Application (2020-2025)
7.4 Global Hepatitis B Vaccination Sales Growth Rate by Application (2020-2025)

8 HEPATITIS B VACCINATION MARKET SALES BY REGION

8.1 Global Hepatitis B Vaccination Sales by Region
  8.1.1 Global Hepatitis B Vaccination Sales by Region
  8.1.2 Global Hepatitis B Vaccination Sales Market Share by Region
8.2 Global Hepatitis B Vaccination Market Size by Region
  8.2.1 Global Hepatitis B Vaccination Market Size by Region
  8.2.2 Global Hepatitis B Vaccination Market Size by Region
8.3 North America
  8.3.1 North America Hepatitis B Vaccination Sales by Country
  8.3.2 North America Hepatitis B Vaccination Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Hepatitis B Vaccination Sales by Country
  8.4.2 Europe Hepatitis B Vaccination Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Hepatitis B Vaccination Sales by Region
  8.5.2 Asia Pacific Hepatitis B Vaccination Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Hepatitis B Vaccination Sales by Country
  8.6.2 South America Hepatitis B Vaccination Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Hepatitis B Vaccination Sales by Region
  8.7.2 Middle East and Africa Hepatitis B Vaccination Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 HEPATITIS B VACCINATION MARKET PRODUCTION BY REGION

9.1 Global Production of Hepatitis B Vaccination by Region(2020-2025)
9.2 Global Hepatitis B Vaccination Revenue Market Share by Region (2020-2025)
9.3 Global Hepatitis B Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hepatitis B Vaccination Production
  9.4.1 North America Hepatitis B Vaccination Production Growth Rate (2020-2025)
  9.4.2 North America Hepatitis B Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hepatitis B Vaccination Production
  9.5.1 Europe Hepatitis B Vaccination Production Growth Rate (2020-2025)
  9.5.2 Europe Hepatitis B Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hepatitis B Vaccination Production (2020-2025)
  9.6.1 Japan Hepatitis B Vaccination Production Growth Rate (2020-2025)
  9.6.2 Japan Hepatitis B Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hepatitis B Vaccination Production (2020-2025)
  9.7.1 China Hepatitis B Vaccination Production Growth Rate (2020-2025)
  9.7.2 China Hepatitis B Vaccination Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 GSK
  10.1.1 GSK Basic Information
  10.1.2 GSK Hepatitis B Vaccination Product Overview
  10.1.3 GSK Hepatitis B Vaccination Product Market Performance
  10.1.4 GSK Business Overview
  10.1.5 GSK SWOT Analysis
  10.1.6 GSK Recent Developments
10.2 NCPC
  10.2.1 NCPC Basic Information
  10.2.2 NCPC Hepatitis B Vaccination Product Overview
  10.2.3 NCPC Hepatitis B Vaccination Product Market Performance
  10.2.4 NCPC Business Overview
  10.2.5 NCPC SWOT Analysis
  10.2.6 NCPC Recent Developments
10.3 Merck
  10.3.1 Merck Basic Information
  10.3.2 Merck Hepatitis B Vaccination Product Overview
  10.3.3 Merck Hepatitis B Vaccination Product Market Performance
  10.3.4 Merck Business Overview
  10.3.5 Merck SWOT Analysis
  10.3.6 Merck Recent Developments
10.4 Bio Kangtai
  10.4.1 Bio Kangtai Basic Information
  10.4.2 Bio Kangtai Hepatitis B Vaccination Product Overview
  10.4.3 Bio Kangtai Hepatitis B Vaccination Product Market Performance
  10.4.4 Bio Kangtai Business Overview
  10.4.5 Bio Kangtai Recent Developments
10.5 Dynavax
  10.5.1 Dynavax Basic Information
  10.5.2 Dynavax Hepatitis B Vaccination Product Overview
  10.5.3 Dynavax Hepatitis B Vaccination Product Market Performance
  10.5.4 Dynavax Business Overview
  10.5.5 Dynavax Recent Developments
10.6 Hissen
  10.6.1 Hissen Basic Information
  10.6.2 Hissen Hepatitis B Vaccination Product Overview
  10.6.3 Hissen Hepatitis B Vaccination Product Market Performance
  10.6.4 Hissen Business Overview
  10.6.5 Hissen Recent Developments
10.7 KM Biologics
  10.7.1 KM Biologics Basic Information
  10.7.2 KM Biologics Hepatitis B Vaccination Product Overview
  10.7.3 KM Biologics Hepatitis B Vaccination Product Market Performance
  10.7.4 KM Biologics Business Overview
  10.7.5 KM Biologics Recent Developments
10.8 LG Life Sciences
  10.8.1 LG Life Sciences Basic Information
  10.8.2 LG Life Sciences Hepatitis B Vaccination Product Overview
  10.8.3 LG Life Sciences Hepatitis B Vaccination Product Market Performance
  10.8.4 LG Life Sciences Business Overview
  10.8.5 LG Life Sciences Recent Developments
10.9 Serum Institute
  10.9.1 Serum Institute Basic Information
  10.9.2 Serum Institute Hepatitis B Vaccination Product Overview
  10.9.3 Serum Institute Hepatitis B Vaccination Product Market Performance
  10.9.4 Serum Institute Business Overview
  10.9.5 Serum Institute Recent Developments

11 HEPATITIS B VACCINATION MARKET FORECAST BY REGION

11.1 Global Hepatitis B Vaccination Market Size Forecast
11.2 Global Hepatitis B Vaccination Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Hepatitis B Vaccination Market Size Forecast by Country
  11.2.3 Asia Pacific Hepatitis B Vaccination Market Size Forecast by Region
  11.2.4 South America Hepatitis B Vaccination Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Hepatitis B Vaccination by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Hepatitis B Vaccination Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Hepatitis B Vaccination by Type (2026-2035)
  12.1.2 Global Hepatitis B Vaccination Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Hepatitis B Vaccination by Type (2026-2035)
12.2 Global Hepatitis B Vaccination Market Forecast by Application (2026-2035)
  12.2.1 Global Hepatitis B Vaccination Sales (K MT) Forecast by Application
  12.2.2 Global Hepatitis B Vaccination Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hepatitis B Vaccination Market Size by Type (M USD)
Table 4. Global Hepatitis B Vaccination Market Size by Application
Table 5. Hepatitis B Vaccination Market Size Comparison by Region (M USD)
Table 6. Global Hepatitis B Vaccination Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Hepatitis B Vaccination Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hepatitis B Vaccination Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hepatitis B Vaccination Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccination as of 2025)
Table 11. Global Market Hepatitis B Vaccination Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Hepatitis B Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hepatitis B Vaccination Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hepatitis B Vaccination Sales by Type (K MT)
Table 27. Global Hepatitis B Vaccination Market Size by Type (M USD)
Table 28. Global Hepatitis B Vaccination Sales (K MT) by Type (2020-2025)
Table 29. Global Hepatitis B Vaccination Sales Market Share by Type (2020-2025)
Table 30. Global Hepatitis B Vaccination Market Size (M USD) by Type (2020-2025)
Table 31. Global Hepatitis B Vaccination Market Share by Type (2020-2025)
Table 32. Global Hepatitis B Vaccination Price (USD/KG) by Type (2020-2025)
Table 33. Global Hepatitis B Vaccination Sales (K MT) by Application
Table 34. Global Hepatitis B Vaccination Market Size by Application
Table 35. Global Hepatitis B Vaccination Sales by Application (2020-2025) & (K MT)
Table 36. Global Hepatitis B Vaccination Sales Market Share by Application (2020-2025)
Table 37. Global Hepatitis B Vaccination Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hepatitis B Vaccination Market Share by Application (2020-2025)
Table 39. Global Hepatitis B Vaccination Sales Growth Rate by Application (2020-2025)
Table 40. Global Hepatitis B Vaccination Sales by Region (2020-2025) & (K MT)
Table 41. Global Hepatitis B Vaccination Sales Market Share by Region (2020-2025)
Table 42. Global Hepatitis B Vaccination Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hepatitis B Vaccination Market Size by Region (2020-2025)
Table 44. North America Hepatitis B Vaccination Sales by Country (2020-2025) & (K MT)
Table 45. North America Hepatitis B Vaccination Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hepatitis B Vaccination Sales by Country (2020-2025) & (K MT)
Table 47. Europe Hepatitis B Vaccination Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hepatitis B Vaccination Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Hepatitis B Vaccination Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hepatitis B Vaccination Sales by Country (2020-2025) & (K MT)
Table 51. South America Hepatitis B Vaccination Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hepatitis B Vaccination Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Hepatitis B Vaccination Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hepatitis B Vaccination Production (K MT) by Region(2020-2025)
Table 55. Global Hepatitis B Vaccination Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hepatitis B Vaccination Revenue Market Share by Region (2020-2025)
Table 57. Global Hepatitis B Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Hepatitis B Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Hepatitis B Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Hepatitis B Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Hepatitis B Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. GSK Basic Information
Table 63. GSK Hepatitis B Vaccination Product Overview
Table 64. GSK Hepatitis B Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. GSK Business Overview
Table 66. GSK SWOT Analysis
Table 67. GSK Recent Developments
Table 68. NCPC Basic Information
Table 69. NCPC Hepatitis B Vaccination Product Overview
Table 70. NCPC Hepatitis B Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. NCPC Business Overview
Table 72. NCPC SWOT Analysis
Table 73. NCPC Recent Developments
Table 74. Merck Basic Information
Table 75. Merck Hepatitis B Vaccination Product Overview
Table 76. Merck Hepatitis B Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Merck Business Overview
Table 78. Merck SWOT Analysis
Table 79. Merck Recent Developments
Table 80. Bio Kangtai Basic Information
Table 81. Bio Kangtai Hepatitis B Vaccination Product Overview
Table 82. Bio Kangtai Hepatitis B Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bio Kangtai Business Overview
Table 84. Bio Kangtai Recent Developments
Table 85. Dynavax Basic Information
Table 86. Dynavax Hepatitis B Vaccination Product Overview
Table 87. Dynavax Hepatitis B Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Dynavax Business Overview
Table 89. Dynavax Recent Developments
Table 90. Hissen Basic Information
Table 91. Hissen Hepatitis B Vaccination Product Overview
Table 92. Hissen Hepatitis B Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Hissen Business Overview
Table 94. Hissen Recent Developments
Table 95. KM Biologics Basic Information
Table 96. KM Biologics Hepatitis B Vaccination Product Overview
Table 97. KM Biologics Hepatitis B Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. KM Biologics Business Overview
Table 99. KM Biologics Recent Developments
Table 100. LG Life Sciences Basic Information
Table 101. LG Life Sciences Hepatitis B Vaccination Product Overview
Table 102. LG Life Sciences Hepatitis B Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. LG Life Sciences Business Overview
Table 104. LG Life Sciences Recent Developments
Table 105. Serum Institute Basic Information
Table 106. Serum Institute Hepatitis B Vaccination Product Overview
Table 107. Serum Institute Hepatitis B Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Serum Institute Business Overview
Table 109. Serum Institute Recent Developments
Table 110. Global Hepatitis B Vaccination Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Hepatitis B Vaccination Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Hepatitis B Vaccination Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Hepatitis B Vaccination Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Hepatitis B Vaccination Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Hepatitis B Vaccination Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Hepatitis B Vaccination Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Hepatitis B Vaccination Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Hepatitis B Vaccination Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Hepatitis B Vaccination Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Hepatitis B Vaccination Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Hepatitis B Vaccination Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Hepatitis B Vaccination Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Hepatitis B Vaccination Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Hepatitis B Vaccination Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Hepatitis B Vaccination Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Hepatitis B Vaccination Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Hepatitis B Vaccination
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hepatitis B Vaccination Market Size (M USD), 2025-2035
Figure 5. Global Hepatitis B Vaccination Market Size (M USD) (2020-2035)
Figure 6. Global Hepatitis B Vaccination Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hepatitis B Vaccination Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hepatitis B Vaccination Product Life Cycle
Figure 13. Hepatitis B Vaccination Sales Share by Manufacturers in 2025
Figure 14. Global Hepatitis B Vaccination Revenue Share by Manufacturers in 2025
Figure 15. Hepatitis B Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hepatitis B Vaccination Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hepatitis B Vaccination Revenue in 2025
Figure 18. Industry Chain Map of Hepatitis B Vaccination
Figure 19. Global Hepatitis B Vaccination Market PEST Analysis
Figure 20. Global Hepatitis B Vaccination Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hepatitis B Vaccination Market Share by Type
Figure 27. Sales Market Share of Hepatitis B Vaccination by Type (2020-2025)
Figure 28. Sales Market Share of Hepatitis B Vaccination by Type in 2025
Figure 29. Market Share of Hepatitis B Vaccination by Type (2020-2025)
Figure 30. Market Share of Hepatitis B Vaccination by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hepatitis B Vaccination Market Share by Application
Figure 33. Global Hepatitis B Vaccination Sales Market Share by Application (2020-2025)
Figure 34. Global Hepatitis B Vaccination Sales Market Share by Application in 2025
Figure 35. Global Hepatitis B Vaccination Market Share by Application (2020-2025)
Figure 36. Global Hepatitis B Vaccination Market Share by Application in 2025
Figure 37. Global Hepatitis B Vaccination Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hepatitis B Vaccination Sales Market Share by Region (2020-2025)
Figure 39. Global Hepatitis B Vaccination Market Size by Region (2020-2025)
Figure 40. North America Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Hepatitis B Vaccination Sales Market Share by Country in 2024
Figure 43. North America Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hepatitis B Vaccination Market Size by Country in 2024
Figure 45. U.S. Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hepatitis B Vaccination Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Hepatitis B Vaccination Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hepatitis B Vaccination Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hepatitis B Vaccination Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Hepatitis B Vaccination Sales Market Share by Country in 2024
Figure 53. Europe Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hepatitis B Vaccination Market Size by Country in 2024
Figure 55. Germany Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hepatitis B Vaccination Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Hepatitis B Vaccination Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hepatitis B Vaccination Market Size by Region in 2024
Figure 68. China Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hepatitis B Vaccination Sales and Growth Rate (K MT)
Figure 79. South America Hepatitis B Vaccination Sales Market Share by Country in 2024
Figure 80. South America Hepatitis B Vaccination Market Size and Growth Rate (M USD)
Figure 81. South America Hepatitis B Vaccination Market Size by Country in 2024
Figure 82. Brazil Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hepatitis B Vaccination Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Hepatitis B Vaccination Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hepatitis B Vaccination Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hepatitis B Vaccination Market Size by Region in 2024
Figure 92. Saudi Arabia Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hepatitis B Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Hepatitis B Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hepatitis B Vaccination Production Market Share by Region (2020-2025)
Figure 103. North America Hepatitis B Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Hepatitis B Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Hepatitis B Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 106. China Hepatitis B Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Hepatitis B Vaccination Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Hepatitis B Vaccination Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hepatitis B Vaccination Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hepatitis B Vaccination Market Share Forecast by Type (2026-2035)
Figure 111. Global Hepatitis B Vaccination Sales Forecast by Application (2026-2035)
Figure 112. Global Hepatitis B Vaccination Market Share Forecast by Application (2026-2035)